Short Interest in BlackRock Health Sciences Trust (NYSE:BME) Increases By 102.7%

BlackRock Health Sciences Trust (NYSE:BME) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 15,000 shares, an increase of 102.7% from the December 31st total of 7,400 shares. Based on an average daily trading volume, of 56,200 shares, the days-to-cover ratio is currently 0.3 days.

BlackRock Health Sciences Trust Price Performance

NYSE BME traded down $0.19 on Wednesday, reaching $40.44. The stock had a trading volume of 17,746 shares, compared to its average volume of 63,264. BlackRock Health Sciences Trust has a 12-month low of $36.87 and a 12-month high of $42.75. The business’s 50-day moving average price is $38.94 and its 200 day moving average price is $40.49.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently disclosed a monthly dividend, which will be paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th will be given a $0.2621 dividend. This represents a $3.15 annualized dividend and a yield of 7.78%. The ex-dividend date is Wednesday, January 15th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Fountainhead AM LLC acquired a new stake in shares of BlackRock Health Sciences Trust during the third quarter valued at $204,000. AlphaStar Capital Management LLC purchased a new position in BlackRock Health Sciences Trust during the fourth quarter worth about $878,000. Janney Montgomery Scott LLC lifted its position in BlackRock Health Sciences Trust by 40.5% during the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares during the period. Consolidated Portfolio Review Corp lifted its stake in shares of BlackRock Health Sciences Trust by 7.2% in the 3rd quarter. Consolidated Portfolio Review Corp now owns 42,574 shares of the company’s stock valued at $1,785,000 after purchasing an additional 2,853 shares in the last quarter. Finally, Wolverine Asset Management LLC lifted its position in BlackRock Health Sciences Trust by 42.4% during the third quarter. Wolverine Asset Management LLC now owns 85,565 shares of the company’s stock valued at $3,588,000 after buying an additional 25,457 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.